These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 34689383)

  • 21. Left Ventricular Assist Devices or Inotropes for Decreasing Pulmonary Vascular Resistance in Patients with Pulmonary Hypertension Listed for Heart Transplantation.
    Al-Kindi SG; Farhoud M; Zacharias M; Ginwalla MB; ElAmm CA; Benatti RD; Oliveira GH
    J Card Fail; 2017 Mar; 23(3):209-215. PubMed ID: 27374840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased frequency of heart transplantation, shortened waitlist time and preserved post-transplant survival in adults with congenital heart disease, on the new heart transplant allocation system.
    Jani M; Cook S; Huang SH; Boeve T; Leacche M; Manandhar-Shrestha NK; Jovinge SV; Loyaga-Rendon RY
    Clin Transplant; 2021 Apr; 35(4):e14205. PubMed ID: 33368608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Socioeconomic Status on Patients Supported With a Left Ventricular Assist Device: An Analysis of the UNOS Database (United Network for Organ Sharing).
    Clerkin KJ; Garan AR; Wayda B; Givens RC; Yuzefpolskaya M; Nakagawa S; Takeda K; Takayama H; Naka Y; Mancini DM; Colombo PC; Topkara VK
    Circ Heart Fail; 2016 Oct; 9(10):. PubMed ID: 27758810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Temporal trends and outcomes of patients waiting on left ventricular assist devices and inotropes for heart transplantation.
    Briasoulis A; Adegbala O; Akintoye E; Alvarez P
    Clin Transplant; 2020 Jun; 34(6):e13857. PubMed ID: 32167606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World".
    Fernandez Valledor A; Rubinstein G; Moeller CM; Lorenzatti D; Rahman S; Lee C; Oren D; Farrero M; Sayer GT; Uriel N
    J Heart Lung Transplant; 2024 Jun; 43(6):1010-1020. PubMed ID: 38360159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of heart transplant allocation change on competing waitlist outcomes among listing strategies.
    Patel JN; Chung JS; Seliem A; Sakr A; Stoletniy L; Rabkin DG; Abramov D
    Clin Transplant; 2021 Jul; 35(7):e14345. PubMed ID: 33977552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States.
    Wever-Pinzon O; Naka Y; Garan AR; Takeda K; Pan S; Takayama H; Mancini DM; Colombo P; Topkara VK
    J Heart Lung Transplant; 2016 Jul; 35(7):884-92. PubMed ID: 27151597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.
    Kitada S; Schulze PC; Jin Z; Clerkin K; Homma S; Mancini DM
    Int J Cardiol; 2016 Jan; 203():929-935. PubMed ID: 26618255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of Implantable Cardioverter-Defibrillators and Wait-List Mortality of Patients Supported with Left Ventricular Assist Devices as Bridge to Heart Transplantation.
    Younes A; Al-Kindi SG; Alajaji W; Mackall JA; Oliveira GH
    Int J Cardiol; 2017 Mar; 231():211-215. PubMed ID: 28043679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal membrane oxygenation as a bridge to advanced heart failure therapies.
    Acharya D; Manandhar-Shrestha N; Leacche M; Rajapreyar I; William P; Kazui T; Hooker R; Tonna J; Jovinge S; Loyaga-Rendon R
    J Heart Lung Transplant; 2023 Aug; 42(8):1059-1071. PubMed ID: 36964083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impella 5.5 as a bridge to heart transplantation: Waitlist outcomes in the United States.
    Cevasco M; Shin M; Cohen W; Helmers MR; Weingarten N; Rekhtman D; Wald JW; Iyengar A
    Clin Transplant; 2023 Oct; 37(10):e15066. PubMed ID: 37392194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure.
    Schumer EM; Ising MS; Trivedi JR; Slaughter MS; Cheng A
    Ann Thorac Surg; 2015 Aug; 100(2):522-7. PubMed ID: 26070601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Institutional volume of heart transplantation with left ventricular assist device explantation influences graft survival.
    Haglund NA; Feurer ID; Ahmad RM; DiSalvo TG; Lenihan DJ; Keebler ME; Schlendorf KH; Stulak JM; Wigger MA; Maltais S
    J Heart Lung Transplant; 2014 Sep; 33(9):931-6. PubMed ID: 24925183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late right heart failure during support with continuous-flow left ventricular assist devices adversely affects post-transplant outcome.
    Takeda K; Takayama H; Colombo PC; Jorde UP; Yuzefpolskaya M; Fukuhara S; Mancini DM; Naka Y
    J Heart Lung Transplant; 2015 May; 34(5):667-74. PubMed ID: 25577566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strategies of Wait-listing for Heart Transplant vs Durable Mechanical Circulatory Support Alone for Patients With Advanced Heart Failure.
    Lala A; Rowland JC; Ferket BS; Gelijns AC; Bagiella E; Pinney SP; Moskowitz AJ; Miller MA; Pagani FD; Mancini DM
    JAMA Cardiol; 2020 Jun; 5(6):652-659. PubMed ID: 32293643
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mortality in status 2 patients listed for heart transplantation in the United States: Will understanding cause of death help justify implantation of left ventricular assist devices into less sick patients?
    Morris AA; Chen C; Laskar SR; Smith AL; Vega JD
    Int J Cardiol; 2019 Feb; 276():185-190. PubMed ID: 30482444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices.
    Gelow JM; Song HK; Weiss JB; Mudd JO; Broberg CS
    J Heart Lung Transplant; 2013 Nov; 32(11):1059-64. PubMed ID: 23921356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.